Image

Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Trial: Testing INBRX-109 for advanced solid tumors, including sarcomas.

Recruiting
12-85 years
All
Phase 1

This study tests a new drug called INBRX-109 for people with advanced solid tumors, including sarcomas, which are types of cancer. It is a phase 1 trial, meaning it is the first time this drug is being tested in humans. The study will look at how safe the drug is and how it affects the body.

Eligibility: Participants should be between 12 and 84 years old, depending on the specific type of tumor. They must have tumors that cannot be treated with standard therapies. They must also have good organ function and good overall health.

Exclusion: People who have used similar drugs, had certain treatments recently, or have other health issues, like severe liver disease, are not allowed. Pregnant or nursing women cannot join.

  • The study is divided into three parts and is not randomized, meaning participants will all get the study drug.
  • Participants will need to stop certain medications and treatments before joining.
  • There will be regular health checks and monitoring throughout the study.

This trial provides a new treatment opportunity for those with few other options, but it's important to consider the risks and requirements before joining.

Study details
    Colorectal Adenocarcinoma
    Ewing Sarcoma

NCT03715933

Inhibrx Biosciences, Inc

29 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.